The QualityStocks Daily Monday, September 29th, 2025

Today's Top 3 Investment Newsletters

Schaeffer's(WOLF) $22.1000 +1,726.45%

QualityStocks(BQ) $9.7500 +233.22%

Market Munchies(ENTA) $15.1600 +91.90%

The QualityStocks Daily Stock List

Boqii Holding Ltd (BQ)

StockEarnings, StocksEarning, QualityStocks, The Online Investor, StreetInsider, MarketClub Analysis, MarketBeat, InvestorPlace, FreeRealTime and Broad Street reported earlier on Boqii Holding Ltd (BQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Boqii Holding Ltd (NYSE: BQ) is a holding firm that operates a pet-focused platform. The firm has its headquarters in Shanghai, the People’s Republic of China and was incorporated in December 2007 by Chen Di, Tang Yingzhi and Liang Hai. It mainly serves consumers in China.

The company mainly operates through its subsidiaries and sells its products through online and offline channels, to pet hospitals and stores. It also owns an online platform known as Boqii Mall through which it sells its pet products under the Mocare and Yoken brands. The company has an interactive and informative content platform dubbed Boqii Community which enables users to discover new ways and products that can make their pets happier and healthier as well as share their pet parenting experiences.

The enterprise offers services through its subsidiaries. It is primarily engaged in the sale of pet-related products like pet foods and accessories, which includes oxygen pumps, temperature control equipment, aquatic fertilizer, fish tanks, pet toys, pet bathing products, pet grooming products, health products and pet foods. This is in addition to offering animal care services. Additionally, the enterprise is involved in online information and marketing services place and business advertisements for brand owners.

Boqii Holding Ltd (BQ), closed Monday's trading session at $9.75, up 233.2194%, on 49,414,827 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $1.5188/$18.

cbdMD Inc. (YCBD)

Schaeffer's, InvestorPlace, MarketBeat, QualityStocks, FreeRealTime, StockMarketWatch, CFN Media Group, The Street, StockEarnings, MarketClub Analysis, 360 Wall Street, Red Chip, Wealth Insider Alert, StreetInsider, Top Pros' Top Picks and Money Morning reported earlier on cbdMD Inc. (YCBD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

cbdMD Inc. (NYSE American: YCBD) is a pharmaceutical firm that is engaged in the production and distribution of cannabidiol (CBD) products.

The firm has its headquarters in Charlotte, North Carolina and was incorporated in 2015, on March 17th by Caryn Dunayer. Prior to its name change in May 2019, the firm was known as Level Brands Inc. It operates as part of the pharmaceutical and medicine manufacturing industry, in the health care sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company operates and owns consumer hemp-based CBD brands like Paw CBD and cbdMD. It distributes its products through different brick and mortar retailers across the United States, as well as through wholesalers, 3rd party e-commerce sites and its e-commerce website.

The enterprise’s product categories include animal treats and oils, CBD-infused topical creams, CBD-infused bath bombs, CBD gummies, capsules and CBD tinctures. It provides veterinarian-formulated products like topicals, chews and tinctures under its Paw CBD brand. Under its cbdMD brand, it offers CBD sleep aids, CBD vape oils, CBD bath salts, bath bombs, CBD oil capsules, CBD topicals, CBD gummies and tinctures. All the enterprise’s products are THC-free and have undergone 3rd party testing to ensure their safety.

cbdMD Inc. (YCBD), closed Monday's trading session at $1.38, up 121.1538%, on 198,867,551 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.59/$6.5384.

Tilray, Inc. (TLRY)

QualityStocks, Schaeffer's, StockEarnings, InvestorPlace, CannabisNewsWire, StocksEarning, The Street, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Zacks, BUYINS.NET, Investopedia, Early Bird, Premium Stock Alerts, CFN Media Group, CNBC Breaking News, INO Market Report, StreetAuthority Daily, The Street Report, Daily Profit, Earnings360, FreeRealTime, Top Pros' Top Picks, The Night Owl, InsiderTrades, Inside Trading, Prism MarketView, InvestmentHouse, Trading For Keeps, The Rich Investor, Tip.us, Trading Concepts, Investment House, AllPennyStocks, Daily Wealth, Eagle Financial Publications, Money Morning, wyatt research newsletter, Wealth Daily, VectorVest, TradersPledge, TipRanks, TheTradingReport, StrategicTechInvestor, Stock Up Featured, MarketClub, Outsider Club, Investors Alley, 360 Wall Street, Marketbeat.com, Market Munchies, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground, InvestorsObserver Team and Rick Saddler reported earlier on Tilray, Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tilray, Inc. (NASDAQ: TLRY) is a pharmaceutical firm that is engaged in research, growing, production and distribution of cannabinoids, recreational and medical marijuana. The firm operates through its Hemp and Cannabis Segments.

The firm’s Hemp segment sales are made up of broad spectrum hemp extract that contains CBD, hemp food and hemp seed, which are sold directly to consumers, or to wholesalers and retailers, in unlicensed operations. On the other hand, its Cannabis segment sales are made up of medical, adult-use and huge sales of marijuana under regulated licenses, which are sold directly to patients as well as to governments, pharmacies, wholesalers and retailers. The firm also provides its products to researchers for commercial purposes, as well as for clinical research applications and compassionate access.

Tilray was founded on January 24 in 2018 and is based in Nanaimo, Canada. The firm operates in other countries apart from Canada, including the United Kingdom, Argentina, the U.S., Australia, Switzerland, Chile, South Africa, Portugal, Croatia, New Zealand, Cyprus, Ireland, the Czech Republic, Israel and Germany.

Tilray develops marijuana based medicines, drops, dried marijuana and marijuana extracts, as well as oil products. The firm sells these products through various brands under it, including Manitoba Harvest, Dubon and Canaca. The firm’s subsidiary - FHF Holdings Ltd, also markets, manufactures and distributes consumer products that are hemp-based. Apart from a partnership with AB InBev to develop marijuana-infused drinks, the company recently announced that it would be merging with Aphria Inc., another Canadian cannabis firm.

Tilray, Inc. (TLRY), closed Monday's trading session at $1.85, up 60.8696%, on 373,798,687 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.3507/$1.86.

Dogwood Therapeutics (DWTX)

MarketClub Analysis, Tim Bohen, QualityStocks, Premium Stock Alerts and MarketBeat reported earlier on Dogwood Therapeutics (DWTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dogwood Therapeutics Inc. (NASDAQ: DWTX) is a development-stage biotechnology firm engaged in the development of new therapeutics and sodium channel blocker to treat moderate-to-severe chemotherapy-induced neuropathic pain, cancer pain, and other pain indications.

The firm has its headquarters in Alpharetta, Georgia and was incorporated in 2012. Prior to its name change in October 2024, the firm was known as Virios Therapeutics Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm primarily serves consumers in the United States.

Dogwood Therapeutics focuses on advancing novel antiviral therapies to treat illnesses linked to a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its lead product candidate, Halneuron, is in Phase IIb development as a non-opioid, Nav 1.7 inhibitor developed to treat the neuropathic pain associated with chemotherapy treatment. The enterprise also develops IMC-1, a proprietary, fixed-dose combination of famciclovir and celecoxib designed to synergistically suppress herpes virus replication, with the end goal of reducing virally promoted disease symptoms. This formulation has been developed to treat fibromyalgia and has even received fast track designation by the FDA. In addition, it develops IMC-2, a combination of valacyclovir and celecoxib for the treatment and management of the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID.

Dogwood Therapeutics (DWTX), closed Monday's trading session at $7.91, up 43.2971%, on 43,109,638 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $1.62/$29.28.

Curaleaf Hldgs, Inc. (CURLF)

CannabisNewsWire, QualityStocks, InvestorPlace, Kiplinger Today, MarketBeat, Cabot Wealth, Daily Trade Alert, Top Pros' Top Picks, The Online Investor, MarketClub Analysis, Profit Trends, Wealth Insider Alert, StreetInsider, Early Bird, Trading For Keeps, Trades Of The Day, The Street, TradersPro, Prism MarketView, StreetAuthority Daily, Schaeffer's, Zacks, Wyatt Investment Research, Daily Profit, CFN Media Group, wyatt research newsletter and Investment U reported earlier on Curaleaf Hldgs, Inc. (CURLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Curaleaf Hldgs, Inc. is a foremost vertically integrated medical and wellness cannabis operator in the U.S. The Company crafts premier cannabis products and its commitment is to being the industry’s foremost resource in education and advancement via research and advocacy. Curaleaf Hldgs’ shares trade on the OTC Markets Group’s OTCQX. The Company is based in Wakefield, Massachusetts.

Curaleaf has a presence in 14 states. It owns and operates 53 dispensaries, 15 cultivation sites, and 24 processing sites with an emphasis on highly populated, limited license States. These include Florida, Massachusetts, New Jersey and New York.

Curaleaf is positioned as a leading source for premium cannabis products. The Company’s brands include Select Cannabis, Curaleaf Hemp, and UKU Cannabis. Curaleaf has a team of physicians, pharmacists, medical experts and industry visionaries. Through this team the Company has created a premier, branded, cannabis-based wellness offering under the Curaleaf brand.

Curaleaf’s premium branded products include oils for vaporizing, cartridges, concentrates, tinctures, mints, capsules, edibles, and flower pods. Strain-specific terpene profiles have been launched in every State. The Company’s dedicated dispensary team have served greater than 165,000 registered patients since the inception of operations in each medical State.

Curaleaf Hldgs, Inc. (CURLF), closed Monday's trading session at $3.22, up 37.0213%, on 3,465,602 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.675/$3.65.

Vireo Health International, Inc. (VREOF)

QualityStocks, TradersPro, The Street and InvestorPlace reported earlier on Vireo Health International, Inc. (VREOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vireo Health International collaborates with research organizations to better understand medical cannabis, its applications, and its safety. These partnerships help to reinforce and improve the scientific foundation of the beneficial effects of cannabis and its ability to treat an assortment of medical conditions.

Vireo Health’s physician-led team of employees provides best-in-class cannabis products and customer experiences. The Company manufactures pharmaceutical-grade cannabis products in environmentally-friendly greenhouses. It distributes its products by way of its increasing network of Green Goods™ retail dispensaries and hundreds of third-party locations.

The Company’s present core medical markets of New York, Minnesota, Pennsylvania, Arizona, New Mexico, and Maryland all have the potential to enact adult-use legalization in the next 24 months. In addition, two additional markets in Puerto Rico and Massachusetts have potential for commercialization.

Vireo Health International, Inc. (VREOF), closed Monday's trading session at $0.65, up 32.6531%, on 288,611 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.232/$0.8.

Healthy Choice Wellness (HCWC)

Premium Stock Alerts and QualityStocks reported earlier on Healthy Choice Wellness (HCWC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Healthy Choice Wellness Corp. (NYSE American: HCWC) is a holding company engaged in the operation of organic and natural retail stores.

The firm has its headquarters in Hollywood, Florida and was incorporated in 2022. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm primarily serves consumers in the United States.

Healthy Choice Wellness focuses on offering its consumers healthier daily choices with respect to nutrition and other lifestyle alternatives. It operates through its wholly-owned subsidiaries Healthy Choice Markets 2 LLC, Healthy Choice Markets Inc., Healthy Choice Markets 3 LLC, Healthy Choice Markets IV LLC, Healthy Choice Markets V LLC, and Healthy Choice Markets VI LLC.

The enterprise operates Ada’s Natural Market, a natural and organic grocery store which offers fresh produce, bulk foods, vitamins, and supplements, packaged groceries, meat and seafood, baked goods, dairy products, frozen foods, health & beauty products and natural household items; GreenAcres Market, an organic and natural health food and vitamin chain; Greens Natural Foods, an organic produce and all-natural, and non-GMO groceries and bulk foods; Paradise Health & Nutrition, a natural and organic grocery store; Ellwood Thompson’s, an organic and natural health food and vitamin store; and Mother Earth’s Storehouse, an organic and health food and vitamin store. In addition, it operates Healthy Choice Wellness Center, a center that provides multiple intramuscular shots and vitamin drip mixes for clients, as well as IV vitamin mixes and shots for health, beauty, and re-hydration. Furthermore, it sells vitamins, supplements, beauty and personal care products on its website www.TheVitaminStore.com.

The firm is committed to its expansion strategy and remains focused on driving profitability as it works to deliver sustained value to its shareholders. This may in turn encourage additional investments into Healthy Choice Wellness while bolstering its overall growth.

Healthy Choice Wellness (HCWC), closed Monday's trading session at $0.7, up 5.2315%, on 397,853 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.29/$2.73.

McEwen (MUX)

QualityStocks, MiningNewsWire, SmallCapRelations, SeriousTraders, MissionIR, InvestorBrandNetwork, Tiny Gems, Stocks to Buy Now, Tip.us, StocksToBuyNow, Rocks & Stocks, SmallCapSociety, AINewsWire, NetworkNewsWire, MarketClub Analysis, Wall Street Resources, MarketBeat, Gold Investment Letter, Schaeffer's, Super Stock Picker, The Street, StockOodles, Zacks, StreetInsider, TradersPro, Energy and Capital, Hit and Run Candle Sticks, Pennybuster, Investment House, Uncommon Wisdom, BUYINS.NET, Wealth Daily, InvestorPlace, Top Pros' Top Picks, Streetwise Reports, Marketbeat.com, Stock Beast, rocksandstocks, Market FN, Lebed.biz, The Best Newsletters, Money and Markets, Money Morning, INO.com Market Report, StreetAuthority Daily, StockMarketWatch, Cabot Wealth, Stock Gumshoe and AllPennyStocks reported earlier on McEwen (MUX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

McEwen (NYSE: MUX) (TSX: MUX) announced that its Los Azules copper project in San Juan Province has been approved to participate in Argentina’s Large Investment Incentive Regime (RIGI), as confirmed by Minister of Economy Luis Caputo. The designation consolidates a US$2.672 billion investment plan covering exploration, construction, and operations, marking a historic step for the project, which is set to become Argentina’s first producer of high-purity copper cathodes.

The RIGI approval affirms both the technical and financial strength of Los Azules and its sustainability model, which emphasizes renewable energy, minimal water use, and long-term contributions to local development. Los Azules is projected to generate over US$30 billion in export revenues, create significant employment, and boost provincial and national tax inflows. “This approval reinforces McEwen Copper’s long-term commitment to Argentina and the Province of San Juan,” said Michael Meding, Vice President of McEwen Copper and General Manager of the Los Azules Project.

To view the full press release, visit https://ibn.fm/fqDhT

About McEwen Inc.

McEwen Inc. is a gold and silver producer with operations in the Americas: Nevada (USA), Canada, Mexico, and Argentina. In addition, the company holds 46.4% of McEwen Copper, developer of the advanced-stage Los Azules copper project. Los Azules aims to be Argentina’s first regenerative copper mine, targeting carbon neutrality by 2038. A June 2023 Preliminary Economic Assessment (PEA) estimates a $2.7 billion after-tax NPV (8%) at $3.75/lb Cu, a 27-year mine life, and copper resources of 10.9 billion lbs at 0.40% Cu Indicated plus 26.7 billion lbs at 0.31% Cu Inferred. For PEA details, visit McEwen’s press release .

The company’s shares are publicly traded on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) under the symbol “MUX”.

McEwen (MUX), closed Monday's trading session at $16.66, up 7.1383%, on 2,797,373 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $6.38/$17.18.

Aurora Cannabis (ACB)

InvestorPlace, Schaeffer's, CannabisNewsWire, StocksEarning, QualityStocks, MarketClub Analysis, MarketBeat, StockEarnings, The Street, Trades Of The Day, Daily Trade Alert, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Kiplinger Today, CFN Media Group, StockMarketWatch, Investopedia, Stock Up Featured, Profit Trends, Early Bird, BUYINS.NET, Jim Cramer, BlackSwanAlert, Zacks, TheoTrade, StreetAuthority Daily, The Rich Investor, CNBC Breaking News, Inside Trading, Daily Profit, Cannabis Financial Network News, Investors Alley, Investors Underground, Market Intelligence Center, Market Munchies, Outsider Club, Technology Profits Daily, The Wealth Report, TheTradingReport, Top Pros' Top Picks, Tradespoon, Wall Street Window and Money and Markets reported earlier on Aurora Cannabis (ACB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSE: ACB) (FRA: 21P1) is engaged in the production, distribution and sale of cannabis and cannabis-derived products.

The firm has its headquarters in Edmonton, Canada and was incorporated in 2006, on December 21st by Steve Dobler and Terry Booth. It operates as part of the pharmaceutical and medicine manufacturing industry. The firm has twenty-two companies in its corporate family and serves consumers around the globe, with a focus on Canada.

The company’s brand portfolio includes Woodstrock, Aurora, WMMC, Aurora Drift, Whistler, San Rafael ’71, CanniMed, Daily Special, MedReleaf and AltaVie.

The enterprise produces a number of strains of dried marijuana, marijuana oil and capsules and topical kits for medical patients. It also sells consumable vaporizer accessories, vaporizers, and herb mills for using its herbal cannabis products. This is in addition to selling vaporizer lockable containers and grinders. It also engages in facility engineering and design, marijuana plant breeding, research, production, product development, derivatives, retail and wholesale distribution activities. The enterprise is also involved in the development of medical marijuana products at different stages of development, including edible, topical, oral and inhalable products, as well as in the operation of a network of cannabis counselling and outreach centers known as CanvasRX. Further, it offers cannabis analytical product testing services, design and construction services, and patient counselling services.

Aurora Cannabis (ACB), closed Monday's trading session at $6.23, up 28.1893%, on 13,206,013 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $3.4216/$6.9102.

VolitionRx (VNRX)

RedChip, MissionIR, StockMarketWatch, QualityStocks, BUYINS.NET, PennyStocks24, Tip.us, FreeRealTime, MarketBeat, MarketClub Analysis, Streetwise Reports, InsiderTrades, TraderPower, Tiny Gems, SeeThruEquity Research, AllPennyStocks, StockHotTips, InvestorPlace, TradersPro, SmallCapStockPlays, PennyOmega, DreamTeamNetwork, CRWEWallStreet, CRWEPicks, CRWEFinance, PennyToBuck, BestOtc and DrStockPick reported earlier on VolitionRx (VNRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it has entered into a co-marketing and services agreement with Hologic Diagenode, part of Hologic Inc. (NASDAQ: HOLX), to promote Volition’s Nu.Q® Discover service. The program offers drug developers and scientists a suite of assays for rapid epigenetic profiling across disease model development, preclinical testing, and clinical studies.

“This is a significant milestone for our Nu.Q® Discover program and will greatly expand customer access to our proprietary Nu.Q® Discover assays, which have an estimated total addressable market of $200 million annually,” said Dr. Jasmine Kway, Chief Executive Officer of Singapore Volition. “We look forward to working with the Hologic team as we strengthen our position in the pharmaco-epigenetics market, to help us to grow our revenues.”

Raphael Werding, Head of Life Sciences at Hologic, commented, “We are delighted to sign this agreement and add Nu.Q® Discover to our service offering. At Hologic, we have extensive experience not only in oncology but also in other disease areas such as cardiovascular, neurodegenerative, immunology and others; disease areas where we believe nucleosome quantification can provide additional valuable biological insights to our biotech, pharma and academic clients.”

Under the agreement, Hologic will co-market Nu.Q® Discover with its customer base for an initial one-year term with the potential to expand into an exclusive provider arrangement subject to further terms.

To view the full press release, visit: https://ibn.fm/Spd1c

About Volition

Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential not only to prolong the life of patients, but also to improve their quality of life.

Volition’s research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and an office in London.

The contents found at Volition’s website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.

For further information, visit the company’s website at www.Volition.com .

VolitionRx (VNRX), closed Monday's trading session at $0.623, up 2.9752%, on 359,752 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $0.3951/$0.94.

Quantum BioPharma (QNTM)

QualityStocks, SmallCapRelations, BioMedWire, InvestorBrandNetwork, MissionIR, SeriousTraders, StocksToBuyNow, Tip.Us, NetworkNewsWire, TinyGems, SmallCapSociety, Stocks to Buy Now, TechMediaWire, Tiny Gems, Fierce Analyst, StockWireNews, 360 Wall Street, Premium Stock Alerts and Timothy Sykes reported earlier on Quantum BioPharma (QNTM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced the results of its annual general and special meeting of shareholders held Sept. 26, 2025, in Toronto, with shareholders representing 12 Class A multiple voting shares—entitling holders to 276,660 votes per share—and 1,769,228 Class B subordinate voting shares present in person or by proxy, accounting for 100% of Class A votes and 46.352% of Class B votes.

To view the full press release, visit https://ibn.fm/D5GzF

About Quantum BioPharma Ltd.

Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“ Lucid ”), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented unbuzzd(TM) and spun out its OTC version to a company, Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.), led by industry veterans. Quantum BioPharma retains ownership of 20.11% (as of March 31, 2025) of Unbuzzd Wellness Inc. The agreement with Unbuzzd Wellness Inc. also includes royalty payments of 7% of sales from unbuzzd(TM) until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Quantum BioPharma (QNTM), closed Monday's trading session at $16.19, off by 0.7965686%, on 100,460 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $2.7/$38.25.

Fathom Nickel (FNICF)

QualityStocks, InvestorBrandNetwork, SmallCapRelations, SeriousTraders, MissionIR, MiningNewsWire, Tiny Gems, Stocks to Buy Now, Tip.us, StocksToBuyNow, NetworkNewsWire, Rocks & Stocks, SmallCapSociety, AllPennyStocks, InvestorIntel, Investor News and rocksandstocks reported earlier on Fathom Nickel (FNICF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) announced that geology crews have returned to its Gochager Lake Project to conduct additional prospecting and portable X-ray fluorescence (pXRF) geochemistry on newly exposed outcrops revealed by recent wildfires. Early work has confirmed favourable gabbroic-pyroxenite rock types and anomalous geochemistry extending 1.4 km along strike east-northeast of the historic deposit, with chip sampling and assays underway to further define what is emerging as a mineralized corridor. CEO and VP Exploration Ian Fraser said the wildfire exposure has opened new ground for exploration and is expected to add definition to the expanded footprint, with full soil and rock geochemistry results anticipated by mid-October.

To view the full press release, visit: https://ibn.fm/zBloC

About Fathom Nickel Inc.

Fathom is a junior exploration company focused on exploring for and developing world class nickel camps in the province of Saskatchewan.

Fathom Nickel (FNICF), closed Monday's trading session at $0.01936, off by 7.8095%, on 374,839 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.01293/$0.04274.

The QualityStocks Company Corner

Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM)

The QualityStocks Daily Newsletter would like to spotlight Silvercorp Metals Inc. (TSX.V: SVM) (NYSE American: SVM).

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced that all matters set out in its Aug. 11, 2025 Notice of Meeting and Information Circular were approved by the requisite majority of votes at the company's annual general meeting held today, with 108,216,233 common shares—representing 49.50% of outstanding shares as of the record date—represented at the meeting.

To view the full press release, visit https://ibn.fm/zLTzT

Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) is a Canadian mining company producing silver, gold, lead, and zinc, with a long history of profitability and growth. The company focuses on creating shareholder value by generating free cash flow from long-life mines, expanding through organic growth opportunities in China and Ecuador, and pursuing strategic mergers and acquisitions. Silvercorp has built a reputation as a low-cost producer with a commitment to responsible mining practices.

With over 18 years of operating experience, Silvercorp has developed a diversified portfolio of mining assets and investments in China, Ecuador, and Bolivia. The company leverages its expertise in exploration and operational efficiency to enhance the value of its projects while maintaining a strong balance sheet. Silvercorp’s disciplined approach to mine expansion and resource development ensures long-term sustainable growth.

The company’s mission is to build and operate profitable mines that generate sustainable economic, social, and environmental benefits for stakeholders. Silvercorp is committed to responsible mining, with a focus on environmental stewardship and community engagement.

The company is headquartered in Vancouver, Canada.

Portfolio

Silvercorp operates a diverse portfolio of producing mines, construction-stage projects, and exploration assets across multiple jurisdictions. The company focuses on optimizing production from existing operations while strategically advancing new projects to drive future growth.

  • Ying Mining District (China) – The company’s flagship operation consists of several underground mines producing silver, gold, lead and zinc in concentrates. In fiscal 2025, Ying produced 6.9 million ounces of silver and 7,495 ounces of gold, along with lead and zinc by-products. Fiscal 2026 guidance calls for continued production growth as ongoing mine optimization efforts continue to bear fruit.
  • GC Mine (China) – A silver-lead-zinc mine with a history of consistent production and ongoing resource expansion through drilling. While production dipped slightly in fiscal 2025, output is expected to increase in fiscal 2026.
  • El Domo (Ecuador) – A fully-permitted, copper-gold project under construction. In April 2025, Silvercorp announced a detailed and fully-funded $240.5 million construction plan. Major contracts have been awarded and construction activities are underway, with commissioning expected by December 2026.
  • Condor Project (Ecuador) – A gold exploration asset with significant resources. In May 2025, Silvercorp published an updated mineral resource estimate focusing on high-grade underground zones. A revised PEA is expected by the end of 2025, alongside continued permitting and community engagement efforts.
  • Kuanping Project (China) – A permitted gold-lead-zinc satellite project north of Ying. Mine construction is underway and Kuanping will be an underground mine with ore to be milled at the Ying complex.
  • BYP Mine (China) – A gold-lead-zinc project that operated previously and is now undergoing permitting as a gold mine.
  • Bolivian Assets – Silvercorp holds a 28% stake in New Pacific Metals (TSX: NUAG, NYSE American: NEWP), providing indirect exposure to two world class silver projects: Silver Sand and Carangas.

Through its diversified portfolio, Silvercorp delivers exposure to operations generating growing cash-flow, as well as high-potential growth projects that will create long-term value for shareholders.

Market Opportunity

The global demand for silver, gold, and base metals remains strong, driven by industrial applications, investment demand, and renewable energy initiatives. Silvercorp is well positioned to capitalize on rising silver demand, particularly in China, where 80% of the world’s solar panels are manufactured—an industry heavily reliant on silver.

Ecuador’s mining sector is experiencing rapid growth, with government support for foreign investment and infrastructure improvements. Mining exports in the country surged from $275 million in 2018 to $3.3 billion in 2023, highlighting the sector’s increasing economic importance. Silvercorp’s El Domo and Condor projects are poised to become key contributors to Ecuador’s mining expansion.

Industry forecasts indicate continued growth in silver and base metal prices, benefiting producers with strong operational performance and cost controls. Silvercorp’s diversified asset base and low-cost production profile provide resilience against market fluctuations, positioning the company for long-term value creation.

Leadership Team

Rui Feng, Ph.D., Chairman & CEO, founded Silvercorp and has over 30 years of experience in mineral exploration and mining. He has been instrumental in leading the company’s strategic vision, transforming it into a profitable, low-cost silver producer with a diversified asset base. Under his leadership, Silvercorp has expanded its global footprint, acquiring and developing high-value mining projects across China, Ecuador, and Bolivia. Dr. Feng’s expertise in geology and resource development has contributed to major mineral discoveries, and his disciplined approach to capital allocation has positioned the company for long-term growth.

Derek Liu, MBA, CGA, CPA, Chief Financial Officer, brings over two decades of financial leadership experience in the mining sector, overseeing capital allocation, financial strategy, and risk management. He has played a crucial role in maintaining Silvercorp’s strong balance sheet and financial discipline, ensuring the company remains well-capitalized for organic growth and strategic acquisitions. His expertise in financial planning, compliance, and investor relations has supported Silvercorp’s continued profitability and operational efficiency in a competitive global mining landscape.

Lon Shaver, CFA, President, has extensive experience in corporate finance, equity research, and capital markets, providing strategic guidance on business development and investor relations. Before joining Silvercorp, he held senior roles in investment banking and asset management, where he advised mining companies on financing, mergers, and acquisitions. His deep understanding of capital markets and industry dynamics helps drive Silvercorp’s corporate growth initiatives, enhance shareholder value, and strengthen relationships with institutional investors and stakeholders.

Investment Considerations
  • Fiscal 2025 marked record revenues of nearly $299 million, with silver production of 6.9 million ounces and 11% year-over-year growth in silver equivalent output.
  • The company maintains industry-leading margins with an all-in sustaining cost of $12.12 per ounce of silver over the last 12 months, reinforcing its position as a low-cost producer.
  • The company maintains a strong balance sheet with over $369 million in cash and a strategic equity portfolio, ensuring financial flexibility for future growth.
  • The company launched construction of its fully funded El Domo copper-gold mine in 2025, with production expected by the end of 2026.
  • Silvercorp has published an updated mineral resource estimate for the Condor Project and expects to issue a revised PEA by year-end 2025.
  • Silvercorp is committed to strong environmental and social governance practices, holding an MSCI ESG rating of “A” and prioritizing local employment and procurement.

Silvercorp Metals Inc. (NYSE American: SVM), closed Monday's trading session at $6.27, up 3.125%, on 7,236,657 volume. The average volume for the last 3 months is 6,251,073 and the stock's 52-week low/high is $2.87/$6.46.

Recent News

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

NRx Pharmaceuticals (NASDAQ: NRXP) announced it has re-filed its Abbreviated New Drug Application with the U.S. FDA for KETAFREE(TM), a preservative-free IV ketamine formulation, covering all existing approved indications, following FDA approval of its Suitability Petition. Targeting a ketamine market estimated at $750 million annually in the U.S. and projected to reach $3.35 billion globally by 2034, NRx is seeking priority review amid an ongoing drug shortage, citing its patented formulation manufactured with Nephron Pharmaceuticals in South Carolina as a safer alternative free of benzethonium chloride, a preservative linked to neurotoxicity.

To view the full press release, visit https://ibn.fm/O5lcF

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

  • NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
  • NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
  • Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

Investment Considerations
  • NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
  • The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
  • NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
  • HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
  • The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
  • NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Monday's trading session at $3.25, up 10.1695%, on 779,891 volume. The average volume for the last 3 months is 487,235 and the stock's 52-week low/high is $1.1/$6.01.

Recent News

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI (NASDAQ: DVLT) , a leader in AI data experience, valuation, and monetization, announced that IBM (NYSE: IBM) has made a multi-million dollar commitment of resources, including engineering, technical sales, and quantum computing expertise, to support Datavault's platform development and go-to-market growth. The expanded collaboration is expected to accelerate integration of IBM's watsonx.ai and watsonx.governance capabilities, enhance Datavault's product roadmap, and drive enterprise adoption worldwide. "Bringing our resources to support Datavault's mission will help drive the data monetization of which companies of all sizes can take advantage," said Biz Dziarmaga, Head of Americas AI Partnerships at IBM.

To view the full press release, visit https://ibn.fm/00Tyn

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Investment Considerations
  • WiSA Technologies is strategically positioned in the rapidly growing market for wireless and immersive audio solutions, with strong partnerships with leading consumer electronics brands like Samsung, LG, and Bang & Olufsen.
  • The company’s proprietary WiSA E technology is driving innovation in home entertainment, offering a scalable platform that supports advanced audio formats such as Dolby Atmos and DTS:X.
  • WiSA Technologies’ recent licensing agreements with major HDTV brands covering 43% of the Android OS market significantly expand its market reach and revenue potential.
  • Led by an experienced management team with deep industry knowledge, WiSA Technologies is well-equipped to capitalize on the increasing demand for high-quality, wireless audio experiences.
  • With a focus on setting industry standards through the WiSA Association, the company is positioned as a leader in the evolving audio technology landscape, providing a strong foundation for long-term growth.
Additional Resources

Datavault AI Inc. (NASDAQ: DVLT), closed Monday's trading session at $1.15, up 5.5046%, on 151,095,062 volume. The average volume for the last 3 months is 78,575,170 and the stock's 52-week low/high is $0.2512/$2.675.

Recent News

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF)

The QualityStocks Daily Newsletter would like to spotlight Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF).

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) together with partner Lower Nicola Site Services Ltd., announced the long-term expansion of its wholly owned gravel pit (Permit G1519) and completion of construction of its cement ready mix plant. The company has secured two significant permits: a Notice of Departure at the New Craigmont Project allowing extraction of up to 3.0 million tonnes of inert rock material at approximately 1,500 tonnes per day, and an extension of its gravel pit mine life alongside a provincial highway permit received Sept. 5, 2025.

To view the full press release, visit https://ibn.fm/4FXiG

Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. With a unique dual-pronged model, the company combines solid operational revenues from its wholly-owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows Nicola to fund ongoing development while minimizing equity dilution.

The company’s strategy centers on aligning infrastructure and permitting advantages with mineral-rich geology, positioning it to process its own, as well as third-party high-grade gold and silver mines via partnerships, to advance its own exploration targets. Key agreements with gold producers and concentrating sales contracts provide stable cash flow, making Nicola rare among juniors in its ability to internally support growth. Its solid balance sheet and business acumen have allowed it to take stakes in other near-term gold producers, including a 75% economic stake in Dominion Gold, which commences a bulk sample in 2H 2025.

Nicola is leveraging its platform of permitted infrastructure, strategic project locations, and deep technical expertise to build shareholder value in a low-risk, high-reward framework. The company is headquartered in Vancouver, British Columbia.

Projects

Nicola Mining’s project portfolio includes high-grade copper, silver, and gold assets located in mineral-rich regions of British Columbia. Each project is 100%-owned or majority-controlled, with strong exploration potential and the necessary permits to advance development.

New Craigmont Copper Project

Nicola’s flagship asset, the New Craigmont Project, is a historic producer of over 900 million pounds of copper. Since acquiring 100% ownership in 2015, the company has drilled over 18,000 meters and identified significant skarn-hosted and porphyry-style mineralization. Recent drilling in 2024 confirmed 52.9 meters at 1.03% Cu (Hole NC-24-002), supporting the presence of a large-scale copper system. The project benefits from paved road access, connection to BC Hydro’s grid, and proximity to urban centers.

Treasure Mountain Silver Project

This 100%-owned past-producing mine has a Major Mines permit (M-239) and an NI 43-101 compliant resource estimate. The site includes multiple silver-lead-zinc veins and is permitted to extract up to 60,000 tonnes annually. Nicola is evaluating potential reactivation or joint venture options. Resource estimates include indicated resources of 52,000 tonnes grading 18.1 oz/t Ag, 3.26% Pb, and 3.4% Zn, and inferred resources of 161,000 tonnes grading 22.0 oz/t Ag, 2.48% Pb, and 3.86% Zn.

Dominion Creek Project (Au-Ag)

Nicola holds a 50% land ownership and 75% economic stake in this gold-silver project. Located 43 km from Wells, British Columbia, the site has returned grab samples averaging 61.3 g/t Au and 173.7 g/t Ag. The company has received its final permit and plans to extract a 10,000-tonne bulk sample in 2025, which will be processed at its Merritt Mill facility.

Operations

In addition to its exploration assets, Nicola Mining operates a suite of permitted industrial facilities in British Columbia that generate revenue and support the company’s broader development strategy. These assets form the backbone of Nicola’s self-sustaining business model.

Merritt Mill & Tailings Facility

Nicola owns and operates British Columbia’s only provincially permitted toll mill for gold and silver, a $30 million flotation facility located near Merritt. Gold production began in 2023. The facility is supported by long-term Milling and Profit Share Agreements with companies including Osisko Development Corporation, Blue Lagoon Resources, and Talisker Resources.

Sand & Gravel Pit / Rock Quarry / Ready-Mix Concrete Plant

Nicola also operates a permitted gravel pit (100,000 t/year), rock quarry (1,500 t/day), and is set to launch a ready-mix cement plant in Q2 2025. These operations, run in partnership with local First Nations, generate stable cash flow to support exploration efforts.

Market Opportunity

Nicola Mining is uniquely positioned in southern British Columbia, a jurisdiction recognized for its mining-friendly policies, skilled labor force, and robust infrastructure. The New Craigmont Project is geologically situated within the Guichon Creek Batholith, a region hosting some of Canada’s largest copper mines, including Highland Valley. Exploration data from 2023 and 2024 support the potential presence of both skarn and porphyry systems, increasing the strategic value of Nicola’s holdings.

The company’s other assets, including Treasure Mountain and Dominion Creek, are located in historically productive areas with high-grade mineralization and established access routes. Dominion Creek, in particular, sits atop the Isaac Lake Fault system—identified in British Columbia’s RGS (Regional Geochemical Survey) as a highly anomalous gold-silver corridor. Nicola’s integrated production model enables it to generate revenue while advancing these exploration programs without excessive dilution, providing a distinct advantage in a volatile commodities market.

Leadership Team

Peter Espig, Chief Executive Officer & Director, is a former diamond driller who spearheaded Nicola through a restructuring into its recent growth. He brings over $2 billion in private equity transaction experience, is a pioneer of SPACs, and has held senior positions at Goldman Sachs Japan and Olympus Capital.

Will Whitty, VP of Exploration, brings to the company over 15 years of experience in copper and gold exploration. He previously worked at Freeport-McMoRan and Nevada Gold Mines. He holds a master’s degree from the Mineral Deposit Research Unit (MDRU) at the University of British Columbia.

Bill Cawker, Corporate Development, manages investor relations, communications, and corporate governance. He joined Nicola in 2023 and brings extensive small-cap public markets experience, along with a degree in economics from the University of British Columbia.

Sam Wong, Chief Financial Officer, is a CPA with over 18 years of experience in the mining sector. He previously held executive roles at several publicly listed resource companies. He began his career at Deloitte LLP in Vancouver.

Investment Considerations
  • High-Grade Copper Opportunity: 100% ownership of the New Craigmont Project, one of British Columbia’s most promising high-grade copper exploration targets, strategically located adjacent to Canada’s largest copper mine (Highland Valley Copper).
  • Immediate Revenue Generation: Operates British Columbia’s only permitted mill capable of processing third-party gold and silver ore, with current throughput supporting strong, near-term cash flow.
  • Diverse Revenue Streams: Revenue growth fueled by commercial milling operations, gold concentrate sales, and active aggregate production — providing self-funded exploration and reducing reliance on capital raises.
  • Strategic Location & Infrastructure: Centrally located near major transportation routes and mining services, providing cost advantages and operational efficiencies.
  • Proven Leadership Team: Led by a management group with extensive track records in mining operations, project development, and capital markets, driving disciplined growth and long-term value creation.

Nicola Mining Inc. (OTCQB: HUSIF), closed Monday's trading session at $0.81, up 6.4067%, on 64,267 volume. The average volume for the last 3 months is 168,500 and the stock's 52-week low/high is $0.1498/$0.92.

Recent News

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

ESGold (CSE: ESAU) (OTCQB: ESAUF) is featured in a NetworkNewsAudio Audio Press Release (APR) titled "Wall Street Wants Cash Flow—And This Gold Market Is Finally Delivering." The piece spotlights ESGold's fully funded, fully permitted operations with expected cash flow in early 2026, exploration upside without dilution, and a scalable model for legacy mining assets, positioning the company as a standout among juniors in a sector where fewer than 0.1% of projects ever reach production.

To view the full press release, visit https://ibn.fm/oV9py

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Monday's trading session at $0.5989, up 7.2337%, on 281,994 volume. The average volume for the last 3 months is 738,430 and the stock's 52-week low/high is $0.03/$1.1.

Recent News

Strawberry Fields REIT Inc. (NYSE American: STRW)

The QualityStocks Daily Newsletter would like to spotlight Strawberry Fields REIT Inc. (NYSE American: STRW).

Strawberry Fields REIT, Inc., is a self-administered real estate investment trust, focused on the acquisition of properties that are leased out to skilled nursing and other healthcare businesses

While appearing on The Bell2Bell Podcast, the company's CEO, Moishe Gubin, reflected on the strides made thus far, the milestones achieved, and the company's future

Most notably, Gubin noted the company distributes less than 50% of its AFFO, with the remaining 50% allocated to additional asset purchases which has led to the growth of its AFFO per share of 11% annually

He continued to reiterate the company's commitment to building facilities for America's rapidly increasing aging population

Strawberry Fields REIT (NYSE: AMERICAN: STRW) , a self-administered real estate investment trust engaged in the ownership, acquisition, and leasing of skilled nursing and specific other healthcare-related properties, is celebrating 10 years of operation. While appearing on The Bell2Bell Podcast, CEO Moishe Gubin reflected on the company's success, the milestones it has achieved, and where the company is headed going forward ( https://ibn.fm/A1kOf ).

Strawberry Fields REIT Inc. (NYSE American: STRW) is a self-administered real estate investment trust engaged in the ownership, acquisition, development, and leasing of skilled nursing and other healthcare-related properties. Initially spun out in 2015 with a 33-property portfolio in Indiana and Illinois, the company has steadily expanded its footprint and now owns and leases across 10 states. Its facilities are leased to experienced third-party operators, primarily under long-term triple-net agreements.

The company’s disciplined strategy emphasizes working with regional operators and experienced consultants, focusing on markets where demographic tailwinds and regulatory barriers support long-term demand. From 2020 through projected 2025, the company achieved compound annual growth rates of 13.6% in Adjusted Funds From Operations (AFFO) and 13.5% in Adjusted EBITDA (AEBITDA).

In August 2025, the board of directors approved a 14.3% increase in the company’s quarterly dividend to $0.16 per share. Chairman and CEO Moishe Gubin stated that the dividend increase reflects the company’s strong performance and sustainable outlook, while still keeping the payout ratio below 50%.

Strawberry Fields REIT is headquartered in South Bend, Indiana.

Portfolio

As of September 2025, Strawberry Fields REIT owns and holds long-term leasehold interests in 142 healthcare facilities totaling more than 15,500 licensed beds. The portfolio includes 130 skilled nursing facilities (SNFs), 10 assisted living facilities (ALFs), and two long-term acute care hospitals (LTACHs), with properties located in Arkansas, Illinois, Indiana, Kansas, Kentucky, Missouri, Ohio, Oklahoma, Tennessee, and Texas.

In recent months, Strawberry Fields REIT has expanded its portfolio through the following acquisitions:

  • Nine skilled nursing facilities in Missouri totaling 686 beds for $59 million. Eight of the facilities were added to an existing master lease with the Tide Group, increasing annual base rent by $5.5 million, while the ninth facility was added to Reliant Care Group’s lease, raising rent by an additional $0.6 million.
  • An 80-bed skilled nursing facility near Oklahoma City, Oklahoma, for $4.25 million, which was leased to a current operator under a master lease with $425,000 of initial rents and 3% annual escalations.
  • A 124-bed facility comprised of 108 skilled nursing beds and 16 assisted living beds near Poplar Bluff, Missouri, for $5.3 million, which was leased to a current operator under a master lease with $530,000of initial rents and 3% annual escalations.

Market Opportunity

Strawberry Fields REIT operates in the skilled nursing and post-acute healthcare real estate sector, which is supported by favorable demographic and regulatory trends. The U.S. population aged 65 and older is expected to exceed 72 million by 2030 and reach 88.5 million by 2050. According to the CDC, 83.5% of skilled nursing facility residents are 65 or older.

The sector benefits from high barriers to entry, including regulatory constraints, capital requirements, and operational complexity. At the same time, government programs such as Medicare and Medicaid provide a stable reimbursement base. The company noted that despite challenges, its operators have demonstrated consistent profitability in states that are traditionally considered difficult for SNF operators.

Spending on SNF care for the aging population is projected to grow from $181.6 billion in 2021 to $273 billion in 2030, reflecting a compound annual growth rate of 4.63%. Strawberry Fields REIT’s geographic clustering strategy and long-term lease structure position it to benefit from this increasing demand and constrained supply.

Leadership Team

Moishe Gubin, Chairman, CEO, and Founder, has served as CEO since the company’s inception and was involved in every acquisition. He previously served as CFO and manager of Infinity Healthcare Management and is a licensed CPA in New York.

Jeffrey Bajtner, Chief Investment Officer and Chief Operating Officer, joined the company in 2021. He oversees acquisitions, dispositions, and investor relations. Previously, he held leadership roles at BlitzLake Partners and NorthStar Realty Finance. He is a licensed CPA in Illinois.

Greg Flamion, Chief Financial Officer, joined in January 2024. He was formerly CFO at Zimmerman Advertising and has held senior finance roles at Diageo and Bristol Myers Squibb. He holds an MBA from the University of Florida and is a CPA licensed in Indiana.

Steven Greenfield, General Counsel, joined in April 2025. He previously served as Managing Attorney at HammondLaw and held executive and legal positions at Weil, Gotshal & Manges LLP and Mayer Brown LLP, focusing on tax and securities law.

Investment Considerations
  • Strawberry Fields REIT generated $18.9 million in AFFO and $8.7 million in net income for the second quarter of 2025.
  • Rental income rose 29% year-over-year, reflecting growth from acquisitions and lease renewals.
  • The company owns and leases 142 healthcare facilities with over 15,500 licensed beds across 10 states.
  • Long-term triple-net leases with built-in escalators support predictable, recurring revenue.
  • Recent acquisitions in Missouri and Oklahoma added $7.1 million in new annual base rent.

Strawberry Fields REIT Inc. (NYSE American: STRW), closed Monday's trading session at $12.3, even for the day, on 38,394 volume. The average volume for the last 3 months is 28,007 and the stock's 52-week low/high is $8.7/$12.9.

Recent News

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced its inclusion in a NetworkNewsWire editorial titled "Soaring Gold Prices Open Doors for Emerging Producers." With gold trading above $3,500 an ounce amid inflation concerns, currency pressures, and slowing global growth, companies nearing production stand to benefit significantly. Positioned for near-term production, LaFleur owns a fully permitted, modernized gold mill and strategically located projects in one of Canada's most productive mining regions, offering a timely value proposition for investors.

To view the full press release, visit https://ibn.fm/LKyrD

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

Investment Considerations
  • LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
  • The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
  • Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
  • LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
  • A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Monday's trading session at $0.409, up 2.8155%, on 173,100 volume. The average volume for the last 3 months is 208,920 and the stock's 52-week low/high is $0.0139/$1.65.

Recent News

SEGG Media Corp. (NASDAQ: SEGG)

The QualityStocks Daily Newsletter would like to spotlight SEGG Media Corp. (NASDAQ: SEGG).

SEGG Media has recently expanded its offering by launching SEGG Digital and SEGG Productions.

The company also created a new corporate website to position itself as a forward-thinking brand amid the beginning of their next phase of growth.

It also recently had representatives from its executive team in Nashville for the season finale of IndyCar, to support the SEGG Media-backed drivers, finalized sponsorships, and to kick the tires on the 2026 SEGG Elite Driver Program.

SEGG Media kicked off the next stage of its progression thanks to strategic acquisitions, strong capital, and global expansion.

On the heels of its rebranding, SEGG Media (NASDAQ: SEGG, LTRYW) has made several recent announcement showcasing its growth and expansion as an organization.

SEGG Media Corp. (NASDAQ: SEGG; LTRYW) is a global sports, entertainment, and gaming company redefining how audiences connect with content through immersive technology and ethical engagement. Formerly known as Lottery.com Inc., the company recently completed a comprehensive corporate transformation, rebranding as SEGG Media (short for Sports Entertainment Gaming Global Media) to reflect its new strategic direction and structural overhaul.

With a mission to fuse real-time experiences, fan-first platforms, and responsible innovation, SEGG Media operates at the intersection of sports, entertainment, and gaming. Its business model is built around three synergistic verticals, each designed to scale globally while delivering meaningful value to fans, partners, and shareholders.

From sim racing and esports to live event streaming and charitable gaming, SEGG Media is building a next-generation platform that redefines how audiences interact with their favorite content and communities.

The company is headquartered in Fort Worth, Texas.

Portfolio

SEGG Media’s operations are structured across three core verticals: Sports.com, Entertainment, and Lottery.com.

  • Sports.com is SEGG’s global hub for immersive sports media, covering sim racing, football, motorsports, and athlete-led content. The vertical includes Sports.com Studios, Sports.com Media, and Nook, each focused on original storytelling and fan-driven experiences. In June 2025, SEGG announced plans to acquire a 51% stake in the sports and technology assets of GXR World to launch the Sports.com Super App, a first-of-its-kind platform combining live streaming, e-commerce, community chat, real-money and fantasy gaming, and sports news. Built on GXR’s tech stack, which already draws over one million monthly active users, the Super App is expected to debut in Q3 2025 with an initial focus on soccer and motorsports.
  • The Entertainment pillar includes AI-driven event streaming, music and fashion media, and hybrid live experiences. As part of its acquisition-led growth model, SEGG is advancing a proposed deal to acquire DotCom Ventures Inc., owner of Concerts.com and TicketStub.com, to build out ticketing, event distribution, and direct-to-fan monetization infrastructure. This initiative aligns with SEGG’s five-year plan to unify content, commerce, and fan engagement under one platform, supported by a $100 million financing facility activated in May 2025.
  • Lottery.com, SEGG’s ethical gaming division, delivers domestic and international lottery access, iGaming, instant wins, sports betting, charitable gaming through properties such as WinTogether, and syndicated results data to more than 800 publishers through Tinbu. With compliance issues resolved and new operating structures in place, the platform is being relaunched globally through Lottery.com International.

Together, these three verticals enable SEGG Media to unify fragmented fan experiences into a fully integrated global ecosystem—where sports, gaming, content, and commerce converge.

Market Opportunity

The global sports betting industry is undergoing rapid expansion as digital adoption accelerates and new markets open to regulation. According to Grand View Research, the sports betting market was valued at $100.9 billion in 2024 and is projected to reach $187.39 billion by 2030, growing at a compound annual growth rate of 11% from 2025 to 2030. This growth is fueled by increased internet penetration, widespread mobile usage, and rising interest in real-time, interactive fan experiences.

Beyond sports betting, SEGG Media also operates in the high-growth arenas of streaming, esports, and AI-powered content delivery. These adjacent markets are seeing double-digit global growth as fans demand more immersive, on-demand, and participatory forms of entertainment. With its diversified platform and strategic positioning across three converging verticals, SEGG Media is built to capitalize on multiple long-term secular trends and unlock scalable revenue opportunities.

Leadership Team

Matthew McGahan, Chief Executive Officer and Chairman, joined the company in October 2022. Since then, he has played a central role in stabilizing operations, restructuring the organization, and guiding its rebrand to SEGG Media. McGahan brings a mix of entrepreneurial drive and philanthropic leadership, having founded the UK-based charity Mask Our Heroes during the COVID-19 pandemic and previously built and sold the Harley-Davidson dealership Magic Automotive Group.

Tim Scoffham, CEO of Sports.com Media and Lottery.com International, brings over 20 years of leadership experience across gaming, media, and digital sports entertainment. Appointed following a successful consultancy period, Scoffham now leads SEGG’s global growth strategy for its iGaming and sports media divisions. He is focused on expanding international operations, aligning media and technology platforms, and driving revenue across high-growth jurisdictions while strengthening regulatory partnerships.

Investment Considerations
  • SEGG Media has completed a comprehensive corporate transformation, including rebranding, structural realignment, and strategic repositioning.
  • The company operates across three synergistic verticals with scalable revenue potential: Sports.com, Entertainment, and Lottery.com.
  • A $100 million financing facility is in place to support its acquisition-driven five-year growth plan.
  • The upcoming launch of the Sports.com Super App is expected to redefine fan engagement across soccer, motorsports, and beyond.
  • SEGG is executing a global expansion strategy through acquisitions such as GXR World and DotCom Ventures.

SEGG Media Corp. (NASDAQ: SEGG), closed Monday's trading session at $4.46, off by 7.2765%, on 79,176 volume. The average volume for the last 3 months is 125,298 and the stock's 52-week low/high is $2.202/$26.45.

Recent News

FAVO Capital Inc. (OTC: FAVO)

The QualityStocks Daily Newsletter would like to spotlight FAVO Capital Inc. (NASDAQ: FAVO).

FAVO Capital (OTC: FAVO) , a diversified financial company with operations in financial services and real estate, announced the appointment of Dr. Wael Barsoum to its board of directors as an independent director. Barsoum, former president and CEO of Cleveland Clinic Florida and current president and chief transformation officer at Healthcare Outcomes Performance Company, brings decades of leadership in healthcare innovation, governance, and organizational growth. "Wael's appointment reflects our commitment to building a board with the independence, depth, and experience to guide FAVO's next chapter," said Shaun Quin, president of FAVO Capital.

To view the full press release, visit https://nnw.fm/gLEvl

FAVO Capital Inc. (OTC: FAVO) is redefining the private credit and alternative lending industry through a strategic redevelopment of its operations and offerings. With a focus on leveraging financial technology and a client-centric approach, FAVO Capital empowers small to medium-sized businesses with fast, flexible, and reliable access to capital, bridging the gap left by traditional financial institutions.

Empowering Businesses, Redefining Private Credit

As part of its strategy to uplist to Nasdaq, FAVO Capital is enhancing its technology platform, operational scalability, and market positioning to meet higher regulatory standards and attract institutional investors. Headquartered in Fort Lauderdale, Florida, FAVO employs over 120 professionals across five global offices, delivering sustainable growth and value for clients and shareholders alike.

Products and Services

  • Proprietary Lending Platform and Mobile App (In Development): FAVO Capital is in the early stages of developing an advanced digital platform designed to enhance client engagement and streamline funding processes. This platform will eventually allow businesses to apply for funding products, track progress, and manage repayment efficiencies. A complementary mobile app is also being planned to provide real-time insights and tailored recommendations, laying the groundwork for an improved borrower experience.
  • Fintech-Driven Lending Solutions: FAVO Capital is exploring proprietary and third-party technology tools, including advanced analytics and algorithms, to enhance decision-making speed and reliability in the lending process.
  • Flexible Financing Options: FAVO specializes in structuring customized capital solutions tailored to the diverse needs of small business owners, offering scalable and adaptable products that evolve with changing market conditions.

Market Opportunity

The private credit market is experiencing exponential growth as traditional banks reduce their focus on small business lending. According to industry reports, the global private credit market is projected to surpass $1.5 trillion by 2025, driven by increasing demand for alternative financing options.

FAVO Capital is uniquely positioned to capture market share within this booming sector by leveraging fintech innovation to meet the needs of underserved small businesses. With a focus on efficiency, speed, and client satisfaction, FAVO addresses critical gaps in the financial ecosystem while building a platform for long-term growth.

Recent Highlights

  • Fintech Innovation: Initial investments in app development and analytics lay the groundwork for future operational efficiency and improved borrower experience.
  • Operational Scale: A global footprint with over 120 employees combines the agility of a local lender with the reach of an international financial institution.
  • Proven Growth: FAVO’s technology-driven approach has enabled consistent expansion, solidifying its reputation as a trusted partner for small businesses.

Leadership Team

Vincent Napolitano is a Founder and CEO of FAVO Capital Inc. With over two decades of experience in finance and business development, Vincent has been instrumental in building FAVO Capital into a trusted partner for businesses seeking innovative financial strategies. Prior to founding FAVO Capital, Vincent spent 25 years on Wall Street, holding key positions at prominent firms and developing expertise in structuring complex financial deals. He also served as Chief Investment Officer for multiple special purpose vehicles (SPVs), acquiring private stock in pre-IPO unicorn companies such as Facebook and Twitter.

Shaun Quin is a Founding Member and President of FAVO Capital Inc., overseeing the company’s mission to deliver innovative and efficient private credit solutions to small and medium-sized businesses. With over 20 years of global experience as a partner, investor, and director, Shaun brings a strategic and customer-focused approach to his leadership. His expertise in fostering collaboration, building high-performance cultures, and empowering businesses has positioned FAVO Capital as a trusted leader in private lending.

Vaughan Korte, CFO, brings over 15 years of global financial expertise to his role with FAVO Capital Inc. His track record includes managing financial operations for Adidas across 60 countries with budgets exceeding $500 million. Vaughan’s leadership ensures FAVO Capital remains financially resilient, aligning financial strategy with organizational goals and fostering shareholder value.

Glen Steward, Chief Strategy Officer, is a seasoned entrepreneur with over 28 years of experience in the investment and trading industries. He drives FAVO Capital’s strategic initiatives, ensuring the company remains competitive and agile in a rapidly evolving market. Glen has held directorships and board memberships across Mauritius, South Africa, and the United States. His strategic acumen has been pivotal in integrating the FAVO Group of Companies into FAVO Capital Inc., fueling growth and market leadership.

Advisory Board

Bilal Adam, Accounting & Financial Counsel, is a financial expert with over 20 years of experience, including roles as CEO of Stewards Investment Capital. His insights into bespoke investment solutions, including fixed income, equity, and digital assets, support FAVO Capital’s innovative approach to private credit.

Honorable Earnest Hart, Corporate Governance Counsel, brings decades of legal and governance experience, having served as a New York Supreme Court Judge and COO at Columbia University Medical Center. His guidance ensures FAVO Capital maintains robust corporate governance standards.

Rocco Trotta, Business Leadership and Scalability Counsel, is the co-founder of LiRo-Hill and has decades of experience scaling businesses. His expertise in organizational efficiency and talent development strengthens FAVO Capital’s ability to attract excellence across all aspects of the business.

As FAVO Capital redevelops its operations and prepares for an uplisting to Nasdaq, the company is laying the foundation to redefine private credit with emerging fintech solutions and exceptional leadership. Learn more by visiting investors.favocap.com.

Investment Considerations
  • Early-Stage Technology Development: Laying the groundwork for proprietary platforms and scalable digital tools.
  • Significant Market Opportunity: The private credit market is projected to exceed $1.5 trillion by 2025, providing exponential growth potential.
  • Scalable Business Model: Automated processes and data-driven decision-making enable rapid scaling with minimal overhead.
  • Customer-Centric Approach: FAVO’s focus on small businesses and flexible financing solutions addresses critical gaps in the financial ecosystem.
  • Experienced Leadership: A forward-thinking executive team ensures strategic growth and innovation.

FAVO Capital Inc. (OTC: FAVO), closed Monday's trading session at $3.79, off by 0.5223234%, on 626 volume. The average volume for the last 3 months is 3,360 and the stock's 52-week low/high is $0.162/$4.3833.

Recent News

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Soligenix is positioning itself to expand its presence in dermatology with a novel therapeutic option for one of the most prevalent autoimmune skin conditions.

The company's current study aims to further assess safety and biological activity of SGX302, as well as generate additional data to guide larger studies.

SGX302 has already demonstrated positive results in a phase 1/2 pilot study.

Psoriasis remains a persistent challenge for millions of patients worldwide, and promising new treatments are being closely watched by the medical and investor communities alike. Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company focused on rare diseases and inflammatory conditions, is advancing its treatment candidate, SGX302, in a phase 2a clinical trial for mild-to-moderate psoriasis. The company has already seen encouraging signals in earlier proof-of-concept work, and with its current study underway, Soligenix is positioning itself to expand its presence in dermatology with a novel therapeutic option for one of the most prevalent autoimmune skin conditions.

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Investment Considerations
  • Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
  • The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
  • Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
  • The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
  • Soligenix is led by an experienced management team with a strong track record of success.

Soligenix Inc. (NASDAQ: SNGX), closed Monday's trading session at $1.11, off by 7.5%, on 1,521,983 volume. The average volume for the last 3 months is 1,123,211 and the stock's 52-week low/high is $1.09/$6.2299.

Recent News

AI Maverick Intel Inc. (OTC: BINP)

The QualityStocks Daily Newsletter would like to spotlight AI Maverick Intel Inc. (OTC: BINP).

AI Maverick Intel Inc. (OTC: BINP) is a technology-forward company focused on transforming how businesses acquire and engage customers through artificial intelligence. With a growth strategy centered on acquiring revenue-generating businesses, the company leverages its proprietary platform to deliver scalable, automated solutions across key sectors including healthcare, biotech, insurance, and transportation.

The company’s vision is to eliminate friction from the customer acquisition process by replacing traditional, resource-heavy outreach with intelligent, automated engagement. Its mission is to empower organizations to connect with their ideal audiences at high velocity, using real-time insights and personalized communication powered by machine learning.

AI Maverick Intel is committed to creating long-term value through innovation, efficiency, and strategic partnerships that enhance operational performance and accelerate growth.

The company is headquartered in Dallas, Texas.

Platform & Operations

AI Maverick’s proprietary technology powers a fully automated, AI-driven prospecting engine that enables businesses to scale customer acquisition without expanding headcount. In July 2025, the company launched its enhanced platform, capable of managing both transactional and consultative sales engagements with human-like fluency.

Key components include:

  • Comprehensive Contact Intelligence – Aggregates millions of structured and unstructured data points to build dynamic profiles highlighting job changes, buying intent, and preferences.
  • Context-Aware Messaging – Adaptive language models tailor tone, timing, and delivery channel for each interaction to maximize engagement.
  • Autonomous Sales Dialogues – Manages discovery questions, handles objections, and schedules follow-ups, traditionally handled by sales reps.

This solution supports two-way communication across the full sales funnel—from quote generation and renewals to needs analysis and solution recommendations. The platform is designed to accelerate deal flow and reduce acquisition costs, with typical deployments completed in under a day.

AI Maverick’s transition into an AI-first company followed its acquisition of the AI Maverick platform in May 2025 and a formal rebrand later that month. The company’s public identity now aligns with its operational direction, targeting continued growth through platform scale and strategic business combinations.

Market Opportunity

AI Maverick Intel operates within the rapidly growing artificial intelligence in marketing sector, where machine learning is being widely adopted to personalize customer engagement, optimize ad performance, and automate sales interactions. According to Grand View Research, the global AI in marketing market was valued at $20.44 billion in 2024 and is projected to reach $82.23 billion by 2030, representing a compound annual growth rate (CAGR) of 25.0% from 2025 to 2030.

This growth is being driven by increased demand for individualized consumer experiences, expanded adoption of social networking platforms, and the continued rise of online shopping. North America currently leads the market with a 32.4% revenue share, while Asia Pacific is expected to see the fastest growth. Key applications include content curation, dynamic ad creation, and real-time audience targeting, which are consistent with the platform’s intended use cases.

As companies across industries prioritize speed, accuracy, and scale in reaching their target audiences, AI Maverick’s automation-first approach positions it to capitalize on a multi-billion-dollar transformation in how modern customer acquisition is executed.

Leadership Team

Wayne Cockburn, Chief Executive Officer, is an experienced business executive with over 25 years of board experience across public and private companies in both the U.S. and Canada. He has held senior leadership roles in healthcare and financial services firms, with past titles including Executive Vice President at MedX Health Corp., Chairman of Niiomed Inc., and President of Pathway Health Corp. He is skilled in M&A, capital markets, governance, and startup development, and holds a bachelor’s degree from York University’s Glendon College.

Investment Considerations
  • The company has recently rebranded and adopted a new strategic direction focused on AI-powered customer acquisition and automated sales engagement.
  • Its proprietary platform enables human-like prospecting and communication at scale across multiple industries, including healthcare, biotech, insurance, and transportation.
  • AI Maverick is executing a roll-up strategy aimed at acquiring and optimizing revenue-generating businesses with strong growth potential.
  • The company is positioned within the AI in marketing sector, which is projected to grow from $20.44 billion in 2024 to $82.23 billion by 2030 at a 25.0% CAGR, according to Grand View Research.
  • The platform’s ability to automate both transactional and consultative sales processes gives it a competitive edge in industries where speed and personalization are critical.

AI Maverick Intel Inc. (OTC: BINP), closed Monday's trading session at $0.0249, even for the day. The average volume for the last 3 months is 8,910 and the stock's 52-week low/high is $0.0162/$0.448.

Recent News

BluSky AI Inc. (OTC: BSAI)

The QualityStocks Daily Newsletter would like to spotlight BluSky AI Inc. (OTC: BSAI).

BluSky AI Inc. (OTC: BSAI) is pioneering the next generation of AI infrastructure through modular, rapidly deployable data centers that meet the escalating compute demands of artificial intelligence, machine learning, and high-performance computing. The company’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions.

Rather than betting on individual AI applications, BluSky AI addresses the universal need for compute power—positioning itself as a foundational layer in the AI revolution. Its infrastructure-first approach enables clients to focus on innovation while the company delivers the critical backbone powering tomorrow’s breakthroughs.

BluSky AI is headquartered in Salt Lake City, Utah.

Products

BluSky AI’s core offering is its SkyMod series of modular data centers—pre-assembled, scalable compute units designed specifically for AI workloads. The flagship SkyMod One delivers 1 MW of compute power in a compact 1,400-square-foot footprint, while the SkyMod XL offers 1.7 MW in 3,000 square feet. These units are fully assembled off-site, tested, and shipped ready for plug-and-play deployment either on BluSky-owned land or client facilities.

SkyMod modules integrate NVIDIA GPUs and are optimized for high-density AI applications such as generative AI, large language models, inference engines, and scientific computing. Built for rapid scaling and high efficiency, each system includes advanced cooling, secure infrastructure, and dynamic workload balancing to support evolving client needs.

The company’s data centers are engineered for sustainability, incorporating renewable energy sources like solar, wind, and geothermal where available. By deploying on powered land assets, BluSky AI shortens lead times and lowers costs, creating a fast, flexible alternative to traditional monolithic data centers.

Market Opportunity

The global data center market was valued at $347.6 billion in 2024 and is projected to reach $652.0 billion by 2030, growing at a CAGR of 11.2%, driven by the rapid expansion of AI, machine learning, and IoT adoption, according to Grand View Research. As enterprises demand faster, more scalable compute solutions, modular infrastructure like BluSky AI’s SkyMod series offers a compelling alternative to legacy data center models.

With North America accounting for over 40% of the global market and the U.S. expected to grow at a 10.7% CAGR from 2025 to 2030, BluSky AI is well-positioned to capture demand for AI-optimized infrastructure that can be deployed rapidly and cost-effectively. By focusing on GPU-centric, modular deployments tied to energy infrastructure, the company addresses a growing gap between compute demand and deployment speed in the AI era.

Leadership Team

Trent D’Ambrosio, Chief Executive Officer, is a seasoned executive with a track record in telecommunications, hedge fund management, and natural resource development. He previously sold the first transatlantic fiber cable, built a successful gold mining company, and now leads BluSky AI with a vision to revolutionize AI infrastructure through strategic energy integration and rapid deployment.

Julien Bedard, Chief Technology Officer, is a pioneering technologist known for launching the first Bitcoin escrow and anti-fraud service. At BluSky AI, he oversees cloud architecture, cybersecurity, infrastructure automation, and the development of AI-native data center technology, ensuring scalability and resilience across deployments.

Dan Gay, Chief Operating Officer, has Fortune 500 executive leadership in telecom, technology, and energy, as well as start-up experience with finance and blockchain companies. At MCI and Qwest, he launched new service and sales centers, and directed National Account Sales. He has been a successful CMO in brand creation, product development, partnerships, and revenue generation programs to expand company awareness, sales, and revenue.

Investment Considerations
  • BluSky AI delivers mission-critical infrastructure supporting AI, ML, and HPC applications.
  • SkyMod modules are prefabricated, scalable, and optimized for rapid plug-and-play deployment.
  • The company’s data center designs emphasize sustainability with support for renewable energy.
  • BluSky’s infrastructure-first model addresses universal AI compute needs across industries.
  • A veteran leadership team combines expertise in telecom, finance, and advanced technologies.

BluSky AI Inc. (OTC: BSAI), closed Monday's trading session at $5.98, up 8.7273%, on 6,965 volume. The average volume for the last 3 months is 3,240 and the stock's 52-week low/high is $0.118/$17.97.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.